Acute-on-chronic liver failure: systemic inflammation and immunosuppression - (2023)

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome - (2024)

Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study - (2023)

Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis - (2022)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection? - (2022)

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) - (2023)

The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis - (2023)

Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure - (2023)

Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges - (2020)

Myostatin is associated with the presence and development of acute-on-chronic liver failure - (2023)